Clinical Research & Studies on DSIP Research on DSIP peaked during the 1970s through early 1990s, with studies primarily focused on insomnia, stress regulation, pain modulation, and neuroendocrine function
Its FDA-approved for reducing visceral adipose tissue, particularly in HIV-associated lipodystrophy, but its effects translate well for general fat loss in the abdominal region
If they persist, it could indicate an issue (though with high-purity GHK-Cu like ours, this is exceedingly rare)
Psychiatry 4 (12), e489
We've seen firsthand the varied approaches researchers take, and we constantly refine our offerings, including our 5 Amino 1mq product, to meet the most stringent demands
However, retatrutide is not yet FDA approved and availability is limited to clinical trials and research settings